Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 137
Filter
1.
Med Mycol ; 62(10)2024 Oct 04.
Article in English | MEDLINE | ID: mdl-39366766

ABSTRACT

The etiology of tinea capitis changes over time, mainly due to trends in migration. We report 19 cases of tinea capitis caused by Microsporum audouinii, an uncommon agent in South America, all of them confirmed by molecular methods. All patients were male. The average age was 6.1 years. Fifteen patients were residents of Rio de Janeiro city and four were from neighboring cities. Among the patients submitted to follow-up, griseofulvin was prescribed for eight of them. Due to medication shortages, terbinafine was prescribed for five patients, needing to be switched in three cases, with a bigger total average time until clinical improvement. The study reaffirms the emergence of a new etiological agent in Rio de Janeiro, Brazil.


The etiology of tinea capitis changes over time, mainly due to migratory flows. We report 19 cases of tinea capitis caused by Microsporum audouinii, an uncommon agent in South America, all of them confirmed by molecular methods. The study reaffirms the emergence of a new etiological agent in Rio de Janeiro, Brazil.


Subject(s)
Antifungal Agents , Griseofulvin , Microsporum , Terbinafine , Tinea Capitis , Humans , Tinea Capitis/microbiology , Tinea Capitis/drug therapy , Tinea Capitis/epidemiology , Brazil/epidemiology , Microsporum/isolation & purification , Male , Antifungal Agents/therapeutic use , Child , Child, Preschool , Griseofulvin/therapeutic use , Terbinafine/therapeutic use , Adolescent , Infant
2.
P R Health Sci J ; 43(3): 159-162, 2024 Sep.
Article in English | MEDLINE | ID: mdl-39269769

ABSTRACT

A 6-year-old Hispanic patient presented with a 1-month history of pruritic patches on her scalp, characterized by hair loss, black dots, and dandruff-like scales. The patient was seen by her primary care physician, who prescribed ketoconazole 2% shampoo. This provided little relief for her symptoms, which prompted her admission to nearby hospital, where fluconazole was administered intravenously and mometasone lotion applied. The patient was discharged and instructed to use the ketoconazole shampoo and mometasone lotion. The previously prescribed medications failed to improve her now enlarged, inflamed, scaly, pustule-speckled lesions. Given her condition, she was admitted to the University Pediatric Hospital in San Juan, where the Dermatology Department was consulted. Cultures were taken from the lesions, revealing the presence of Trichophyton tonsurans, which led to the diagnosis of tinea capitis (ringworm of the scalp) with kerion formation. In addition, multiple nits and adult lice characteristic of Pediculus humanus capitis were observed. A 6-week course of griseofulvin, a 1-week course of permethrin solution, and a 5-day course of oral prednisolone were started, effectively cleared the patient's inflammation and fungal infection. This case highlights how there exist areas of improvement in terms of interprofessional communication between physicians, as well a need to increase awareness of the proper treatment for this common pediatric skin condition. We postulate that in doing so, similar cases could be spared the unfortunate results of untreated tinea capitis, that is, kerion formation and the possible scarring this lesion can produce.


Subject(s)
Antifungal Agents , Tinea Capitis , Humans , Tinea Capitis/drug therapy , Tinea Capitis/microbiology , Female , Child , Antifungal Agents/administration & dosage , Time Factors , Griseofulvin/administration & dosage , Treatment Delay
3.
Biofouling ; 38(3): 286-297, 2022 03.
Article in English | MEDLINE | ID: mdl-35450473

ABSTRACT

This study aimed to evaluate the effect of proteinase K on mature biofilms of dermatophytes, by assays of metabolic activity and biomass. In addition, the proteinase K-terbinafine and proteinase K-griseofulvin interactions against these biofilms were investigated by the checkerboard assay and scanning electron and confocal microscopy. The biofilms exposed to 32 µg ml-1 of proteinase K had lower metabolic activity and biomass, by 39% and 38%, respectively. Drug interactions were synergistic, with proteinase K reducing the minimum inhibitory concentration of antifungals against dermatophyte biofilms at a concentration of 32 µg ml-1 combined with 128-256 µg ml-1 of terbinafine and griseofulvin. Microscopic images showed a reduction in biofilms exposed to proteinase K, proteinase K-terbinafine and proteinase K-griseofulvin combinations. These findings demonstrate that proteinase K has activity against biofilms of dermatophytes, and the interactions of proteinase K with terbinafine and griseofulvin improve the activity of drugs against mature dermatophyte biofilms.


Subject(s)
Antifungal Agents , Arthrodermataceae , Antifungal Agents/pharmacology , Biofilms , Endopeptidase K/pharmacology , Griseofulvin/pharmacology , Microbial Sensitivity Tests , Terbinafine/pharmacology
4.
Int J Pharm ; 615: 121498, 2022 Mar 05.
Article in English | MEDLINE | ID: mdl-35065207

ABSTRACT

This study evaluated the ability of different sweeteners to improve dissolution and to form and stabilize supersaturated solutions of griseofulvin (GSF), comparing a eutectic mixture and amorphous formulations. Among the sweeteners tested, only saccharin (SAC) was able to delay drug precipitation in buffer (area under the curve (AUC) increase of 40%) and in fasted state simulated intestinal Fluid (FaSSIF, AUC increase of 20%) compared to pure media. GSF solubility was not affected by the presence of isomalt (ISO), maltitol (MALT) and SAC in buffer pH 6.5 but was reduced in FaSSIF. The quenched cooled amorphous formulation GSF-SAC QC -with the carrier that forms a eutectic mixture with GSF -provided higher drug release in buffer than amorphous formulations with ISO and MALT. In FaSSIF, SAC slightly changed the microenvironment's hydrophobicity (observed in fluorescence studies) and both its amorphous formulation (GSF-SAC QC) and its eutectic mixture (GSF-SAC EM) dissolved at concentrations above drug solubility, achieving supersaturation ratio (SR, Eq. (1)) of 4.14 and 3.15, respectively. The main finding of this study was that for the first time a eutectic mixture acted as a supersaturating drug delivery system, emphasizing the importance of investigating EMs during preformulation studies of fast-crystallizing poorly water-soluble drugs.


Subject(s)
Griseofulvin , Saccharin , Drug Delivery Systems , Drug Liberation , Solubility
5.
Braz. J. Pharm. Sci. (Online) ; 58: e19731, 2022. tab, graf
Article in English | LILACS | ID: biblio-1394038

ABSTRACT

Abstract Poorly water-soluble drugs, such as the antifungal drug griseofulvin (GF), exhibit limited bioavailability, despite their high membrane permeability. Several technological approaches have been proposed to enhance the water solubility and bioavailability of GF, including micellar solubilization. Poloxamers are amphiphilic block copolymers that increase drug solubility by forming micelles and supra-micellar structures via molecular self-association. In this regard, the aim of this study was to evaluate the water solubility increment of GF by poloxamer 407 (P407) and its effect on the antifungal activity against three Trichophyton mentagrophytes and two T. rubrum isolates. The GF water solubility profile with P407 revealed a non-linear behavior, well-fitted by the sigmoid model of Morgan-Mercer-Flodin. The polymer promoted an 8-fold increase in GF water solubility. Fourier-transform infrared (FT-IR) spectroscopy, differential scanning calorimetry (DSC), and 2D nuclear magnetic resonance (NMR Roesy) spectroscopy suggested a GF-P407 interaction, which occurs in the GF cyclohexene ring. These results were supported by an increase in the water solubility of the GF impurities with the same molecular structure. The MIC values recorded for GF ranged from 0.0028 to 0.0172 mM, except for T. Mentagrophytes TME34. Notably, the micellar solubilization of GF did not increase its antifungal activity, which could be related to the high binding constant between GF and P407.


Subject(s)
Solubility , Spectrum Analysis/methods , Trichophyton/classification , Poloxamer/analogs & derivatives , Griseofulvin/agonists , Pharmaceutical Preparations/administration & dosage , Biological Availability , Magnetic Resonance Spectroscopy/methods , Molecular Structure , Antifungal Agents/administration & dosage
6.
Molecules ; 26(23)2021 Dec 02.
Article in English | MEDLINE | ID: mdl-34885898

ABSTRACT

Three endophytic fungi isolated from Moquiniastrum polymorphum (Less.) G. Sancho (Asteraceae) were cultivated using the one strain many compounds (OSMAC) strategy to evaluate the production of griseofulvin derivatives. Extracts obtained were analyzed by HPLC-MS/MS and the chromatographic and spectrometric data used to elaborate a feature-based molecular network (FBMN) through the GNPS platform. This approach allowed the observation of differences such as medium-specific and strain-specific production of griseofulvin derivatives and variations of cytotoxic activity in most extracts. To evaluate the efficiency of the OSMAC approach allied with FBMN analysis in the prospection of compounds of biotechnological interest, griseofulvin and 7-dechlorogriseofulvin were isolated, and the relative concentrations were estimated in all culture media using HPLC-UV, allowing for the inference of the best strain-medium combinations to maximize its production. Malt extract-peptone broth and Wickerham broth media produced the highest concentrations of both secondary metabolites.


Subject(s)
Asteraceae/microbiology , Endophytes/chemistry , Fungi/chemistry , Griseofulvin/analogs & derivatives , Chromatography, High Pressure Liquid , Griseofulvin/analysis , Tandem Mass Spectrometry
7.
J Pediatr ; 234: 269-272, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33794219

ABSTRACT

We examine management practices of tinea capitis at 2 US academic centers. The majority of providers treated tinea capitis with the oral antifungal agent griseofulvin and did not obtain a fungal culture. We recommend newer antifungal treatments such as terbinafine and fluconazole and obtaining a fungal culture for effective treatment.


Subject(s)
Antifungal Agents/therapeutic use , Practice Patterns, Physicians'/statistics & numerical data , Tinea Capitis/diagnosis , Tinea Capitis/drug therapy , Academic Medical Centers , Adolescent , Child , Child, Preschool , Cross-Sectional Studies , Emergency Service, Hospital , Female , Fluconazole/therapeutic use , Griseofulvin/therapeutic use , Humans , Male , Pediatrics , Retrospective Studies , Terbinafine/therapeutic use , United States
8.
Rev Argent Microbiol ; 53(4): 309-313, 2021.
Article in Spanish | MEDLINE | ID: mdl-33618899

ABSTRACT

A descriptive observational and cross-sectional study was carried out. The clinical characteristics, etiologic agents, treatments and outcome of 33 cases of tinea capitis in the Mycology Unit at Francisco J. Muñiz Hospital of Buenos Aires City between January 2015 and December 2019 were analyzed. The median age of the patients was 7 years, 21 of whom were male, 3 were HIV-positive and 22 had pets. The isolated etiologic agents were the following: Microsporum canis in 22 cases, Trichophyton tonsurans in 8, Nannizzia gypsea in 2 and Trichophyton mentagrophytes in one patient. Suppurative tinea capitis (krion Celsi) was detected in 10 cases and the same number of patients presented other skin locations of their dermatophytosis in addition to those in the scalp. Twenty-one cases were orally treated with griseofulvin and 12 with terbinafine. Those patients with suppurative tinea capitis received drops of betamethasone by mouth besides the antifungal drugs. All patients had good clinical and mycological response to the treatments, all lesions disappeared, and mycological studies turned negative by the end of the treatments. We conclude that both drugs were effective for the treatment of tinea capitis; however, lesions in those cases receiving terbinafine involuted more slowly.


Subject(s)
Naphthalenes , Tinea Capitis , Antifungal Agents/therapeutic use , Child , Cross-Sectional Studies , Griseofulvin/therapeutic use , Humans , Male , Terbinafine/therapeutic use , Tinea Capitis/diagnosis , Tinea Capitis/drug therapy , Tinea Capitis/epidemiology , Trichophyton
9.
Life Sci ; 265: 118803, 2021 Jan 15.
Article in English | MEDLINE | ID: mdl-33238167

ABSTRACT

AIMS: According to the WHO, 20-25% of people worldwide are affected by skin infections caused by dermatophytes, such as those of the Trichophyton genus. Additionally, several dermatophytes have developed resistance to drugs such as griseofulvin and itraconazole. This study tested 2S albumins-derived antimicrobial peptides (AMPs) as alternative antidermatophytic molecules. MAIN METHODS: Membrane pore formation assays, tests to detect overproduction of ROS, scanning electron microscopy (SEM) and fluorescence microscopy (FM) were carried out to provide insight into the mechanisms of antidermatophytic action. KEY FINDINGS: All AMPs (at 50 µg mL-1) tested reduced the mycelial growth of T. mentagrophytes and T. rubrum by up to 95%. In contrast, using a concentration 20-fold higher, griseofulvin only inhibited T. mentagrophytes by 35%, while itraconazole was not active against both dermatophytes. Scanning electron and fluorescence microscopies revealed that the six AMPs caused severe damage to hyphal morphology by inducing cell wall rupture, hyphal content leakage, and death. Peptides also induced membrane pore formation and oxidative stress by overproduction of ROS. Based on the stronger activity of peptides than the commercial drugs and the mechanism of action, all six peptides have the potential to be either employed as models to develop new antidermatophytic drugs or as adjuvants to existing ones. SIGNIFICANCE: The synthetic peptides are more efficient than conventional drug to treat infection caused by dermatophytes being potential molecules to develop new drugs.


Subject(s)
Antifungal Agents/pharmacology , Arthrodermataceae/drug effects , Griseofulvin/pharmacology , Itraconazole/pharmacology , Peptide Fragments/pharmacology , Antifungal Agents/chemical synthesis , Arthrodermataceae/physiology , Chemistry Techniques, Synthetic , Griseofulvin/chemical synthesis , Humans , Itraconazole/chemical synthesis , Peptide Fragments/chemical synthesis
10.
Mycoses ; 63(9): 979-992, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32628303

ABSTRACT

BACKGROUND: Dermatophytes belonging to the Trichophyton genus are important human pathogens, but they have developed resistance to griseofulvin, the most common antifungal drug used to treat dermatophytosis. OBJECTIVE: This study was aimed to evaluate the antidermatophytic activity of synthetic peptides, as well as mechanisms of action and synergistic effect with griseofulvin. METHODS: Scanning electron microscopy (SEM), atomic force microscopy (AFM) and fluorescence microscopy (FM) were employed to understand the activity and the mechanism of action of peptides. RESULTS: Here we report that synthetic peptides at 50 µg/mL, a concentration 20-fold lower than griseofulvin, reduced the microconidia viability of T. mentagrophytes and T. rubrum by 100%, whereas griseofulvin decreased their viability by only 50% and 0%, respectively. The action mechanism of peptides involved cell wall damage, membrane pore formation and loss of cytoplasmic content. Peptides also induced overproduction of reactive oxygen species (ROS) and enhanced the activity of griseofulvin 10-fold against both fungi, suggesting synergistic effects, and eliminated the toxicity of this drug to human erythrocytes. Docking analysis revealed ionic and hydrophobic interactions between peptides and griseofulvin, which may explain the decline of griseofulvin toxicity when mixed with peptides. CONCLUSION: Therefore, our results strongly suggest six peptides with high potential to be employed alone as new drugs or as adjuvants to enhance the activity and decrease the toxicity of griseofulvin.


Subject(s)
Antifungal Agents/pharmacology , Griseofulvin/pharmacology , Peptides/chemical synthesis , Peptides/pharmacology , Spores, Fungal/drug effects , Trichophyton/drug effects , Drug Discovery , Drug Resistance, Fungal , Drug Synergism , Humans , Microbial Sensitivity Tests
11.
Eur J Pharm Sci ; 143: 105178, 2020 Feb 15.
Article in English | MEDLINE | ID: mdl-31812717

ABSTRACT

Griseofulvin (GSF) is an antifungal drug that has low aqueous solubility and low oral bioavailability. Amorphous systems are capable to promote rapid drug dissolution, usually affording concentrations above drug solubility in the gastrointestinal tract (supersaturation) in order to promote better absorption. Thus, the aim of this work was to evaluate the ability of amino acids, as hydrophilic carriers, to improve drug kinetic solubilization and to stabilize GSF supersaturated solutions, as well as to stabilize GSF amorphous systems at solid-state. The effect of 5 amino acids on GSF precipitation behavior was investigated by solvent shift method. Amorphous systems were developed by ball milling (GSF + amino acid 1:1 M ratio) and Quench Cooling (to obtain GSF QC) techniques. The samples were characterized by solid-state techniques, submitted to in vitro kinetic solubility studies and evaluated under stability tests. Aspartic acid, methionine, valine and tryptophan demonstrated similar anti-precipitant abilities in phosphate buffer pH 6.5. However, in FaSSIF biorelevant medium, tryptophan was only one able to slow down the drug precipitation. The characterization of milled samples showed that an amorphous system was obtained just using the combination of the drug with tryptophan (GSF-TRYP BM). At the higher dose tested (0.850 mmol L-1) during in vitro kinetic solubility studies, this amorphous system increased the AUC in FaSSGF (88.6%) and FaSSIF (58.2%) media when compared to GSF QC. Thus, the ability of this amino acid to inhibit GSF precipitation appears to be dependent on its concentration in solution and could be optimized. During the stability study, TRYP inhibited GSF recrystallization in the solid-state for a period of 12 months, whereas GSF QC recrystallized in 1 week.


Subject(s)
Amino Acids/chemistry , Antifungal Agents/chemistry , Griseofulvin/chemistry , Chemical Precipitation , Drug Stability , Solubility
12.
J Agric Food Chem ; 66(29): 7627-7632, 2018 Jul 25.
Article in English | MEDLINE | ID: mdl-29944364

ABSTRACT

Sclerotinia sclerotiorum is responsible for the white mold of soybeans, and the difficulty to control the disease in Brazil is causing million-dollar damages. Stachybotrys levispora has shown activity against S. sclerotiorum. In our present investigation, we analyzed the chemical basis of this inhibition. Eight compounds were isolated, and using spectroscopic methods, we identified their structures as the known substances 7-dechlorogriseofulvin, 7-dechlorodehydrogriseofulvin, griseofulvin, dehydrogriseofulvin, 3,13-dihydroxy-5,9,11-trimethoxy-1-methylbenzophenone, griseophenone A, 13-hydroxy-3,5,9,11-tetramethoxy-1-methylbenzophenone, and 12-chloro-13-hydroxy-3,5,9,11-tetramethoxy-1-methylbenzophenone. Griseofulvin inhibited the mycelial growth of S. sclerotiorum at 2 µg mL-1. Thus, the antagonistic effect of S. levispora to S. sclerotiorum may well be due to the presence of griseofulvins. Our results stimulate new work on the biosynthesis of griseofulvins, to locate genes that encode key enzymes in these routes and use them to increase the production of these compounds and thus potentiate the fungicide effect of this fungus. S. levispora represents an agent for biocontrol, and griseofulvin represents a fungicide to S. sclerotiorum.


Subject(s)
Ascomycota/drug effects , Fungicides, Industrial/pharmacology , Griseofulvin/pharmacology , Plant Diseases/prevention & control , Stachybotrys/chemistry , Ascomycota/physiology , Brazil , Fungal Proteins/genetics , Fungal Proteins/metabolism , Fungicides, Industrial/chemistry , Fungicides, Industrial/metabolism , Griseofulvin/chemistry , Griseofulvin/metabolism , Plant Diseases/microbiology , Glycine max/microbiology , Stachybotrys/genetics , Stachybotrys/metabolism
13.
Mycoses ; 61(7): 449-454, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29517824

ABSTRACT

As shown by recent research, most of the clinically relevant fungi, including dermatophytes, form biofilms in vitro and in vivo, which may exhibit antimicrobial tolerance that favour recurrent infections. The aim of this study was to determine the minimum inhibitory concentrations (MICs) of itraconazole (ITC), voriconazole (VCZ) and griseofulvin (GRI) against Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Microsporum canis and Microsporum gypseum in planktonic and biofilm growth. For the planktonic form, susceptibility testing was performed according to the Clinical and Laboratory Standards Institute (CLSI), document M38-A2, while biofilm susceptibility was evaluated using the XTT colorimetric essay. The planktonic growth of all strains was inhibited, with MIC values ranging from 0.00195 to 0.1225 µg/mL for VRC, 0.00195 to 0.25 µg/mL for ITC and <0.0039 to 4 µg/mL for GRI, while a 50-fold increase in the MIC was required to significantly reduce the metabolic activity (P < .05) of dermatophyte biofilms. In brief, the ability of dermatophytes to form biofilms may be a contributing factor for the recalcitrance of dermatophytoses or the dissemination of the disease.


Subject(s)
Antifungal Agents/pharmacology , Arthrodermataceae/drug effects , Azoles/pharmacology , Biofilms/drug effects , Dermatomycoses/veterinary , Griseofulvin/pharmacology , Animals , Arthrodermataceae/growth & development , Biofilms/growth & development , Cat Diseases/microbiology , Cats , Dermatomycoses/microbiology , Dog Diseases/microbiology , Dogs , Humans , Itraconazole/pharmacology , Microbial Sensitivity Tests , Voriconazole/pharmacology
14.
Braz. J. Pharm. Sci. (Online) ; 54(2): e17149, 2018. tab, graf
Article in English | LILACS | ID: biblio-951928

ABSTRACT

ABSTRACT Griseofulvin (GF) and terbinafine (TF) are commonly used drugs to treat dermatophytosis, a fungal infection of the skin. Today there is an increase in drug resistance to these antifungals which highlight the need for alternative synergistic therapies. Minimum Inhibitory Concentration (MIC) of GF and TF were determined against fungi clinical isolates from local hospitals with values ranging 0.03-2.0 µg mL-1 and 0.24-4.0 µg mL-1, respectively. A checkboard test was used to determine the combination of GF:TF which could induce an additive effect against the fungi isolates Multidrug-resistant isolates showed susceptibility after treatment with 16:2 µg mL-1 GF:TF. An MTT assay further verified that GF and TF combinations have greater additive effect against pathological and multidrug-resistant isolates than antifungals alone. Herein we disclose GF:TF combinations that could constitute as a possible new anti-dermatophyte therapy.


Subject(s)
In Vitro Techniques/methods , Drug Combinations , Griseofulvin/analysis , Tinea/pathology , Microbial Sensitivity Tests/instrumentation , Dermatomycoses/classification , Arthrodermataceae/classification , Antifungal Agents/analysis
17.
Porto Alegre; Universidade Federal do Rio Grande do Sul. Telessaúde; 2017. ilus.
Non-conventional in Portuguese | LILACS | ID: biblio-995636

ABSTRACT

Dermatofitoses são infecções cutâneas superficiais causadas por fungos denominados genericamente de dermatófitos (gêneros: Microsporum, Trichophyton e Epidermatophyton) que afetam tecidos queratinizados como pele, cabelos e unhas. Uma vez que estes fungos são encontrados em humanos, animais e no ambiente, o principal fator de risco para o desenvolvimento da doença é o contato direto com animais ou humanos doentes ou portadores. A transmissão também pode ocorrer através do contato com objetos ou ambientes contaminados tais como: escovas de cabelo, roupa de cama, vestiários, carpetes ou outras superfícies contaminadas. O diagnóstico das dermatofitoses costuma ser com base no quadro clínico. Porém, na dúvida diagnóstica ou falha ao tratamento, pode-se solicitar o exame micológico direto para confirmar a infecção. A seguir, são apresentadas as formas mais comuns das dermatofitoses e seus respectivos tratamentos. Esta guia apresenta informação que orienta a conduta para casos de dermatofitoses no contexto da Atenção Primária à Saúde, incluindo: tinea corporis, tinea capitis, tinea cruris, tinea pedis e mannum, encaminhamento para serviço especializado.


Subject(s)
Humans , Tinea/diagnosis , Tinea/therapy , Tinea Capitis/diagnosis , Primary Health Care , /therapeutic use , Griseofulvin/therapeutic use , Antifungal Agents/administration & dosage
18.
Int J Pharm ; 500(1-2): 11-9, 2016 Mar 16.
Article in English | MEDLINE | ID: mdl-26795192

ABSTRACT

Supramolecular gels of poloxamer-hydroxyethyl cellulose (HEC)-α-cyclodextrin (αCD) were developed aiming to obtain synergisms regarding solubilization and sustained release of griseofulvin for topical application. The effects of αCD concentration (0-10%w/w) on the phase behavior of aqueous dispersions of Pluronic(®) P123 (14%w/w) mixed with HEC (2%w/w) were evaluated at 4, 20 and 37°C. The cooperative effects of the inclusion complex formation between poly(ethylene oxide) (PEO) blocks and HEC with αCD prevented phase separation and led to supramolecular networks that solubilize the antifungal drug. Rheological and bioadhesive properties of gels with and without griseofulvin could be easily tuned modulating the polymers proportions. Supramolecular gels underwent sol-gel transition at lower temperature than P123 solely dispersions and enabled drug sustained release for at least three weeks. All gels demonstrated good biocompatibility in the HET-CAM test. Furthermore, the drug-loaded gels showed activity against Trichophyton rubrum and Trichophyton mentagrophytes and thus may be useful for the treatment of tinea capitis and other cutaneous fungal infections.


Subject(s)
Antifungal Agents/chemistry , Cellulose/analogs & derivatives , Griseofulvin/chemistry , Poloxamer/chemistry , alpha-Cyclodextrins/chemistry , Antifungal Agents/administration & dosage , Antifungal Agents/pharmacology , Cellulose/chemistry , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/chemistry , Drug Liberation , Gels , Griseofulvin/administration & dosage , Griseofulvin/pharmacology , Rheology , Solubility , Trichophyton/drug effects
19.
Biomed Res Int ; 2015: 436319, 2015.
Article in English | MEDLINE | ID: mdl-25945334

ABSTRACT

The effect of bile acids administration to an experimental mice model of Protoporphyria produced by griseofulvin (Gris) was investigated. The aim was to assess whether porphyrin excretion could be accelerated by bile acids treatment in an attempt to diminish liver damage induced by Gris. Liver damage markers, heme metabolism, and oxidative stress parameters were analyzed in mice treated with Gris and deoxycholic (DXA), dehydrocholic (DHA), chenodeoxycholic, or ursodeoxycholic (URSO). The administration of Gris alone increased the activities of glutathione reductase (GRed), superoxide dismutase (SOD), alkaline phosphatase (AP), gamma glutamyl transpeptidase (GGT), and glutathione-S-transferase (GST), as well as total porphyrins, glutathione (GSH), and cytochrome P450 (CYP) levels in liver. Among the bile acids studied, DXA and DHA increased PROTO IX excretion, DXA also abolished the action of Gris, reducing lipid peroxidation and hepatic GSH and CYP levels, and the activities of GGT, AP, SOD, and GST returned to control values. However, porphyrin accumulation was not prevented by URSO; instead this bile acid reduced ALA-S and the antioxidant defense enzymes system activities. In conclusion, we postulate that DXA acid would be more effective to prevent liver damage induced by Gris.


Subject(s)
Chemical and Drug Induced Liver Injury/drug therapy , Oxidative Stress/drug effects , Protoporphyria, Erythropoietic/drug therapy , Animals , Catalase/metabolism , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Chenodeoxycholic Acid/administration & dosage , Dehydrocholic Acid/administration & dosage , Deoxycholic Acid/administration & dosage , Glutathione Peroxidase/metabolism , Glutathione Reductase/metabolism , Glutathione Transferase/metabolism , Griseofulvin/toxicity , Humans , Lipid Peroxidation/drug effects , Mice , Porphyrins/metabolism , Protoporphyria, Erythropoietic/chemically induced , Protoporphyria, Erythropoietic/metabolism , Superoxide Dismutase/metabolism , Ursodeoxycholic Acid/administration & dosage
20.
An Bras Dermatol ; 90(2): 251-3, 2015.
Article in English | MEDLINE | ID: mdl-25830999

ABSTRACT

We report the case of a three-year-old child who, following long term treatment with topical corticosteroids and their associations for a case of ringworm on the face developed a form of folliculitis known as Majocchi's Granuloma. Treatment with oral Griseofulvin was successful.


Subject(s)
Facial Dermatoses/pathology , Granuloma/pathology , Tinea/pathology , Antifungal Agents/therapeutic use , Biopsy , Child, Preschool , Facial Dermatoses/drug therapy , Female , Folliculitis/pathology , Granuloma/drug therapy , Griseofulvin/therapeutic use , Humans , Immunocompetence , Skin/pathology , Tinea/drug therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL